Oral versus intravenous ibuprofen for patent ductus arteriosus closure: a randomised controlled trial in extremely low birthweight infants


Creative Commons License

ERDEVE O., YURTTUTAN S., ALTUG N., Ozdemir R., GOKMEN T., DILMEN U., ...More

ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, vol.97, no.4, 2012 (SCI-Expanded) identifier identifier identifier

Abstract

Objective To compare the efficacy and safety of oral versus intravenous ibuprofen for the pharmacological closure of patent ductus arteriosus (PDA) in less mature preterm infants.